TickerFactsScreenerDevelopers

FATE THERAPEUTICS INC (FATE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2007: -$1.22M2008: -$8.35M2009: -$21.46M2010: -$37.44M2011: -$50.68M2012: -$52.83M2013: $50.85M2014: $28.34M2015: $38.04M2016: $73.15M2017: $77.19M2018: $160.47M2019: $244.76M2020: $384.44M2021: $678.84M2022: $483.94M2023: $368.42M2024: $318.73M2025: $207.18M$207.18M
2007Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$207.18M-35.0%
2024$318.73M-13.5%
2023$368.42M-23.9%
2022$483.94M-28.7%
2021$678.84M+76.6%
2020$384.44M+57.1%
2019$244.76M+52.5%
2018$160.47M+107.9%
2017$77.19M+5.5%
2016$73.15M+92.3%
2015$38.04M+34.2%
2014$28.34M-44.3%
2013$50.85M+196.3%
2012-$52.83M-4.2%
2011-$50.68M-35.4%
2010-$37.44M-74.5%
2009-$21.46M-156.9%
2008-$8.35M-585.2%
2007-$1.22M—